Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Lung microbiome: new insights into the pathogenesis of respiratory diseases

Research Progress of Pulmonary Microecology and Its Relationship with Common Pulmonary Diseases

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

The human lung microbiome—A hidden link between microbes and human health and diseases

Lung microbiota: implications and interactions in chronic pulmonary diseases

Emerging Cellular and Molecular Interactions Between the Lung Microbiota and Lung Diseases

Gut microbiota: A new insight into lung diseases

The Lung Microbiome

Role of Microbiota on Lung Homeostasis and Diseases

The Human Respiratory Microbiome: Current Understandings and Future Directions

Lung microbiota and potential treatment of respiratory diseases

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

The Lung Microbiome during Health and Disease

Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Role of the lung microbiome in the pathogenesis of chronic obstructive pulmonary disease.

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

The role of oral microbiome in respiratory health and diseases

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

The lung microbiome: clinical and therapeutic implications

The dynamic lung microbiome in health and disease